BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7684318)

  • 21. Molecular characterization of the genomic breakpoints in a case of t(3;21)(q26;q22).
    Hirai H; Ogawa S; Kurokawa M; Yazaki Y; Mitani K
    Genes Chromosomes Cancer; 1999 Sep; 26(1):92-6. PubMed ID: 10441011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
    Zha S; Isaacs WB
    Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference.
    Bártová E; Harnicarová A; Pacherník J; Kozubek S
    Leuk Res; 2005 Aug; 29(8):901-13. PubMed ID: 15978941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of homeobox gene-GBX2 in human prostatic cancer cells.
    Gao AC; Isaacs JT
    Prostate; 1996 Dec; 29(6):395-8. PubMed ID: 8977637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed in chronic myelogenous leukaemia and located on 9q33-34.1.
    Wu HK; Heng HH; Siderovski DP; Dong WF; Okuno Y; Shi XM; Tsui LC; Minden MD
    Oncogene; 1996 Mar; 12(6):1205-12. PubMed ID: 8649822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells.
    Liang G; Robertson KD; Talmadge C; Sumegi J; Jones PA
    Cancer Res; 2000 Sep; 60(17):4907-12. PubMed ID: 10987305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional activation of human LIM-HOX gene hLH-2 in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
    Wu HK; Minden MD
    Biochem Biophys Res Commun; 1997 May; 234(3):742-7. PubMed ID: 9175786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant expression of the LHX4 LIM-homeobox gene caused by t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic blast crisis.
    Yamaguchi M; Yamamoto K; Miura O
    Genes Chromosomes Cancer; 2003 Nov; 38(3):269-73. PubMed ID: 14506703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Searching for gene expression differences in primary fibroblasts between patients with one and two neoplasms in childhood.
    Victor A; Weis E; Messow CM; Marron M; Haaf T; Spix C; Galetzka D
    Pediatr Hematol Oncol; 2013 Feb; 30(1):33-45. PubMed ID: 23140311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focus on cancer proteomics.
    Collins BC; Gallagher WM
    Proteomics; 2012 Jul; 12(13):2065-6. PubMed ID: 22807453
    [No Abstract]   [Full Text] [Related]  

  • 33. Gene expression: regulation at the RNA and protein levels.
    Biochem Soc Symp; 1989; 55():1-201. PubMed ID: 2482740
    [No Abstract]   [Full Text] [Related]  

  • 34. The RNAissance period.
    Boczkowski D; Nair SK
    Discov Med; 2016 Aug; 22(119):67-72. PubMed ID: 27585232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Return of the 'last ribo-organism'.
    Benner SA; Ellington AD
    Nature; 1988 Apr; 332(6166):688-9. PubMed ID: 2451785
    [No Abstract]   [Full Text] [Related]  

  • 36. The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma.
    Park ER; Kim SB; Lee JS; Kim YH; Lee DH; Cho EH; Park SH; Han CJ; Kim BY; Choi DW; Yoo YD; Yu A; Lee JW; Jang JJ; Park YN; Suh KS; Lee KH
    Cancer Med; 2017 Apr; 6(4):749-760. PubMed ID: 28332314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated expression of the human mitochondrial hinge protein gene in cancer.
    Liu AY; Bradner RC
    Cancer Res; 1993 Jun; 53(11):2460-5. PubMed ID: 7684318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UQCRH gene encoding mitochondrial Hinge protein is interrupted by a translocation in a soft-tissue sarcoma and epigenetically inactivated in some cancer cell lines.
    Modena P; Testi MA; Facchinetti F; Mezzanzanica D; Radice MT; Pilotti S; Sozzi G
    Oncogene; 2003 Jul; 22(29):4586-93. PubMed ID: 12881716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
    Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
    Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.